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In the title quinazolin-4-one derivative, C24H20N2O3, both the
4-methylbenzoate [dihedral angle = 83.90 (9) ] and 2-tolyl
[87.88 (9) ] groups are almost orthogonal to the central fused
ring system. These aryl groups are oriented towards the
quinazolin-4-one-bound methyl group. In the crystal, mol-
ecules are connected into a three-dimensional architecture by
C—H   O, C—H     and  –  [ring centroid-to-centroid
separation = 3.6458 (13) A ˚ ] interactions.
Related literature
For the pharmacological activity of substituted quinazoline-
4(3H)-ones, see: El-Azab & ElTahir (2012); El-Azab et al.
(2011); Al-Omary et al. (2010); Al-Obaid et al. (2009); Aziza et
al. (1996). For the synthesis and evaluation of the anti-
convulsant activity of the title compound, see: El-Azab et al.
(2010). For the structure of the benzoate derivative, see: El-






a = 18.8216 (5) A ˚
b = 7.6332 (2) A ˚
c = 13.3092 (3) A ˚
  = 97.286 (2) 
V = 1896.68 (8) A ˚ 3
Z =4
Cu K  radiation
  = 0.72 mm
 1
T = 100 K
0.25   0.20   0.15 mm
Data collection
Agilent SuperNova Dual
diffractometer with an Atlas
detector
Absorption correction: multi-scan
(CrysAlis PRO; Agilent, 2011)
Tmin = 0.755, Tmax = 1.000
7966 measured reﬂections
3883 independent reﬂections












 max = 1.09 e A ˚  3
 min =  0.33 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
Cg1 is the centroid of the C18–C23 benzene ring.
D—H   AD —H H   AD    AD —H   A
C17—H17C   O2
i 0.98 2.55 3.434 (3) 150
C21—H21   O3
ii 0.95 2.47 3.299 (3) 146
C12—H12   Cg1
iii 0.95 2.79 3.658 (2) 153
Symmetry codes: (i) x;y   1;z; (ii)  x; y; z þ 1; (iii) x; y þ 1
2;z þ 1
2.
Data collection: CrysAlis PRO (Agilent, 2011); cell reﬁnement:
CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to
solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to
reﬁne structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006);
software used to prepare material for publication: publCIF (Westrip,
2010).
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